Oct 18, 2022
Ankit Mahadevia, Co-Founder and CEO for Spero Therapeutics. Ankit focused on novel treatments for Gram Negative infections. He built team responsible for 11 approved antibacterial drugs and raised $97M in private capital across Seed through Series C crossover round to enable construction of multi program late stage infectious disease pipeline and he leads program that achieved positive Phase III outcome in single pivotal trial required for US approval.
Here are some key moments from our conversation: